Condition 1: Schizophrenia. Condition 2: Schizoaffective. Condition 3: Mood disorders. Condition 4: Obsessive- compulsive disorders. Schizophrenia Schizoaffective disorders Mood disorder due to known physiological condition with mixed features Obsessive-compulsive disorder
Conditions
Interventions
Intervention 1: Galantamin 4mg capsules BID in the intervention group until the end of ECT treatment.(for 15 days). Intervention 2: Control group: received placebo capsules BID until the end of ECT t
Sponsors
Sanandaj University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients aged between 18-60 years Patients or their legal guardian must sign an informed consent form Number of sessions of ECT between 4-8
Exclusion criteria
Exclusion criteria: Alcohol & drug abuse or dependence Renal failure Ischemic heart disease Stroke in last 6 months Delirium &Dementia Pregnancy & Lactation History of using Galantamine in past 3 months Galantamine sensitivity Mental retardation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Memory. Timepoint: 1day before begining and after session 3 and after the electroconvulsive therapy. Method of measurement: Wechsler, mini mental statuse examination. | — |
Secondary
| Measure | Time frame |
|---|---|
| Nausea. Timepoint: During intervention( once a day for 15 days). Method of measurement: Patient self report.;Confusion. Timepoint: During intervention(once a day for 15 days). Method of measurement: Patient self report.;Dizziness. Timepoint: During intervention(once a day for 15 days). Method of measurement: Patient self report. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHojat Esfandiyary
Sanandaj University of Medical Sciences
Outcome results
None listed